Balthaser Kevin

Chief Financial Officer

1 company

Average

Trades Analyzed

12M Win Rate

66.7%

Avg 3M Return

-7.1%

Avg 12M Return

+32.0%

Balthaser Kevin is a Chief Financial Officer at Aclaris Therapeutics, Inc.. Recent SEC Form 4 filings include 1 buy and 2 sells.

Estimated insider holdings value: $956K based on current market prices.

Holdings by Company

ACRSJan 2, 2026

Current Shares160.4K

Value$956.1K

Net Activity+7.6K

Bought: 9.5KSold: 1.9K

Showing 2 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M	SEC
Sep 6, 2023	ACRS Aclaris Therapeutics, Inc.	Chief Financial Officer	Buy	9,490	$7.90	$74,971.00	+158.9%	-86.9%	-84.4%
Mar 3, 2023	ACRS Aclaris Therapeutics, Inc.	Chief Financial Officer	Sale+OE	1,894	$12.45	$23,578.52	-16.1%	-31.9%	-90.3%